Unveiling Three ASX Stocks Estimated To Trade Below Their Fair Value
In This Article:
The Australian stock market has shown robust performance, with a 3.0% increase over the last week and a 10% rise over the past year, coupled with an anticipated annual earnings growth of 14%. In this context, identifying stocks that trade below their fair value can offer investors potential opportunities for growth in a flourishing market environment.
Top 10 Undervalued Stocks Based On Cash Flows In Australia
| Name | Current Price | Fair Value (Est) | Discount (Est) |
| Fenix Resources (ASX:FEX) | A$0.40 | A$0.77 | 47.8% |
| MaxiPARTS (ASX:MXI) | A$2.04 | A$3.96 | 48.5% |
| GTN (ASX:GTN) | A$0.435 | A$0.85 | 48.8% |
| hipages Group Holdings (ASX:HPG) | A$1.04 | A$2.06 | 49.5% |
| VEEM (ASX:VEE) | A$1.82 | A$3.54 | 48.6% |
| Strike Energy (ASX:STX) | A$0.21 | A$0.41 | 48.5% |
| Australian Clinical Labs (ASX:ACL) | A$2.42 | A$4.67 | 48.2% |
| ReadyTech Holdings (ASX:RDY) | A$3.25 | A$6.20 | 47.6% |
| Millennium Services Group (ASX:MIL) | A$1.145 | A$2.24 | 48.9% |
| MedAdvisor (ASX:MDR) | A$0.55 | A$1.07 | 48.5% |
Underneath we present a selection of stocks filtered out by our screen.
Flight Centre Travel Group
Overview: Flight Centre Travel Group Limited operates as a travel retailer serving both leisure and corporate sectors across Australia, New Zealand, the Americas, Europe, the Middle East, Africa, Asia, and internationally with a market cap of A$4.88 billion.
Operations: The company's revenue is primarily derived from its leisure and corporate travel services, generating A$1.28 billion and A$1.06 billion respectively.
Estimated Discount To Fair Value: 28.1%
Flight Centre Travel Group, priced at A$22.19, is significantly undervalued based on discounted cash flow analysis, with an estimated fair value of A$30.87. This year marked a return to profitability for the company, enhancing its investment appeal. Additionally, Flight Centre's revenue and earnings growth are projected to outpace the Australian market average at 9.7% and 19.1% per year respectively, supported by a robust forecasted Return on Equity of 21.9% in three years' time.
Regis Healthcare
Overview: Regis Healthcare Limited operates in Australia, providing residential aged care services with a market capitalization of approximately A$1.29 billion.
Operations: The company generates its revenue primarily from residential aged care services, totaling approximately A$882.29 million.